BioSpace News Archive

Leading Approaches to Extracellular Vesicles Therapies

Two financings – and a surprise stock bump – in three days for the some of the most advanced extracellular vesicle (EV) companies show investors are champing at the bit to see the technology unleashed.

March 25, 2021
·
5 min read
·
Mark Zipkin
Business

Neuroscience Company Uncloaks to Fight Chronic Pain, Depression and More

Eliem Therapeutics emerged from stealth mode with $80 million in financing that will be used to develop therapeutics aimed at treating neuronal excitability disorders such as chronic pain, depression, epilepsy and anxiety.

March 25, 2021
·
2 min read
·
Alex Keown
BioSpace Global Roundup: Leyden Labs Secures €40 Million in Series A Financing

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

March 25, 2021
·
6 min read
·
Alex Keown
Deals

Biotechs Bolstering Bank Accounts by Selling Stock This Week

Several new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days.

March 25, 2021
·
2 min read
·
Brandon May
Drug Development

Meissa’s Nasal COVID-19 Vaccine Uses Codon Deoptimization for Stronger Responses

Meissa Vaccines’ intranasal live attenuated chimeric virus-based vaccine for SARS-CoV-2 (and its variants) recently was cleared for Phase I trials, which will start at the end of March.

March 25, 2021
·
4 min read
·
Gail Dutton
Business

Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility

Lyell Immunopharma announced this week that it has completed construction of a $65 million, 70,000-square-foot LyFE Manufacturing Center, which the company will use to support clinical trials and meet cell therapy manufacturing needs.

March 25, 2021
·
3 min read
·
Brandon May
Business

Swift Fall From Grace Continues for Former COVID-19 Vaccine Czar Slaoui

In a stunning fall from grace playing out this week, former Operation Warp Speed vaccine czar, Dr. Moncef Slaoui, issued a statement Thursday morning, as news emerged that he has resigned from additional biotech posts.

March 25, 2021
·
2 min read
·
Heather McKenzie
Business

BioSpace Movers & Shakers, March 26

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

March 25, 2021
·
7 min read
·
Alex Keown
BioMidwest

RiverVest Floods New Fund with $275 Million for Life Sciences Investments

RiverVest Venture Partners announced the closing of its RiverVest Venture Fund V. In an oversubscribed fundraise, they now have $275 million to invest in early-stage biopharma and medical device companies.

March 25, 2021
·
2 min read
·
Mark Terry
BioCapital

Research Roundup: COVID-19 Survivors, Blood Clots and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

March 25, 2021
·
5 min read
·
Mark Terry